|
Table 3. Recommendations |
|
|
|||
|
A. What are the risk factors that can influence the clinical outcome of children with severe AGE? |
|
|
|||
|
N |
Health questions |
Source Guideline |
Recommendations |
Quality of evidence |
Strength of Recommendation |
|
A1 |
ESPGHAN/ESPID 2014 |
Rotavirus is the most severe enteric pathogen of childhood diarrhea. |
Low |
conditional |
|
|
|
|
ESPGHAN/ESPID 2014 |
The high incidence of dehydration in infants<6 months is related to a higher exposure to rotavirus. |
Low |
conditional |
|
|
|
ESPGHAN/ESPID 2014 |
In developing countries, a young age (<6 months) is related to the severity and persistence of diarrhea. |
Intermediate |
Strong |
|
|
|
ESPGHAN/ESPID 2014 |
Children attending day care centers have a greater risk of mild and severe diarrheal illness than children at home. |
Low |
Conditional |
|
|
|
ESPGHAN/ESPID 2014 |
Predominant breast-feeding may reduce the risk of AGE in young European infants. |
Low |
Conditional |
|
|
|
ESPGHAN/ESPID 2014 |
In developing areas early weaning may be associated with earlier onset of severe or prolonged diarrhea. |
Low |
Conditional |
|
|
|
ESPGHAN/ESPID 2014 |
Fever, severe dehydration, and lethargy, which are more common in rotavirus infection, indicate systematic involvement and are associated with severe diarrhea. |
low |
conditional |
|
|
|
ESPGHAN/ESPID 2014 |
In European countries, there is evidence, although weak, of a link between low socioeconomic status and the severity or persistence of diarrhea. |
low |
Conditional |
|
|
|
||||
|
A. Diagnosis |
|
|
|||
|
N |
Health questions |
Source Guideline |
Recommendations |
Quality of evidence |
Strength of Recommendation |
|
B1 |
Indications for medical visit: |
ESPGHAN/ESPID 2014 |
Infants and toddlers with AGE should be referred for medical evaluation if any of the following are present: · Age <2 months · Severe underlying disease (eg. diabetes and renal failure) · Persistent vomiting · High output diarrhea with elevated stool volumes (>8 episodes/day) · Family-reported signs of severe dehydration. |
Low
Very low
Low
Low
low |
Conditiona1
Conditional
Conditional
Conditional
conditional |
|
|
|
||||
|
Diagnosis: Assessment of Dehydration |
|
|
|||
|
N |
Health questions |
Source Guideline |
Recommendations |
Quality of evidence |
Strength of Recommendation |
|
ESPGHAN/ESPID 2014 |
The best measure of dehydration is the percentage loss of body weight. |
Very low |
Conditional |
||
|
|
|
ESPGHAN/ESPID 2014 |
Historical points are moderately sensitive as a measure of dehydration. |
Low |
Conditional |
|
|
|
ESPGHAN/ESPID 2014 |
Classification into subgroups with no or minimal dehydration, mild-moderate dehydration, and severe dehydration is an essential basis for appropriate treatment. |
High |
Strong |
|
|
|
ESPGHAN/ESPID 2014 |
Parental reports of dehydration symptoms are so low in specificity that they may not be clinically useful; however, parental report of normal urine output decreases the likelihood of dehydration. |
Very Low |
Conditional |
|
|
|
ESPGHAN/ESPID 2014 |
Little is known about the severity of diarrhea and/or vomiting and dehydration in industrialized countries; therefore, recommendations are largely based on data from developing countries. In the latter, infants and young children with frequent high-output diarrhea and vomiting are most at risk. |
Low |
Conditional |
|
|
|
ESPGHAN/ESPID 2014 |
Clinical tests for dehydration are imprecise, generally showing only fair-moderate agreement among examiners. |
Low |
Conditional |
|
|
|
ESPGHAN/ESPID 2014 |
It would be helpful to have a common tool to evaluate dehydration. The use of the clinical dehydration scale (CDS) is supported by consistent evidence, and it is easy to use in the assessment of dehydration. |
Low |
Conditional |
|
|
|
ESPGHAN/ESPID 2014 |
This scale should be used in combination with other criteria to guide the need of medical interventions in individual cases. |
Low |
Conditional |
|
Table 6: |
|
|
|||
|
Diagnosis Clinical features suggestive of bacterial versus viral etiology of diarrhea: |
|
|
|||
|
N |
Health questions |
Source Guideline |
Recommendations |
Quality of evidence |
Strength of Recommendation |
|
ESPGHAN/ESPID 2014 |
High fever (>40oC), overt fecal blood, abdominal pain, and central nervous system involvement each suggests a bacterial pathogen. Vomiting and respiratory symptoms are associated with viral etiology.
|
Low |
Conditional |
||
|
Table 7. Recommendations |
|
|
|||
|
Laboratory Diagnosis |
|
|
|||
|
N |
Health questions |
Source Guideline |
Recommendations |
Quality of evidence |
Strength of Recommendation |
|
ESPGHAN/ESPID 2014 |
Acute gastroenteritis does not generally require a specific diagnostic workup. |
Very low |
Conditional |
||
|
|
|
ESPGHAN/ESPID 2014 |
Children presenting with AGE do not require routine etiological investigation; however, there may be particular circumstances in which microbiological investigations may be necessary for diagnosis and treatment. |
Very low |
Conditional |
|
|
|
ESPGHAN/ESPID 2014 |
Microbiological investigations may be considered in children with underlying chronic conditions (eg, oncologic diseases, IBDs, etc), in those in extremely severe conditions, or in those with prolonged symptoms in whom specific treatment is considered. |
Very low |
Conditional |
|
|
|
ESPGHAN/ESPID 2014 |
The differentiation of a bacterial from nonbacterial etiology is not likely to change treatment. C-reactive protein (CRP) and procalcitonin measurements are not routinely recommended to identify a bacterial etiology. |
Very low |
conditional |
|
|
|
ESPGHAN/ESPID 2014 |
Based on available data we do not recommend the routine use of fecal markers to distinguish between viral and bacterial AGE in the clinical setting. |
Very low |
conditional |
|
|
|
ESPGHAN/ESPID 2014 |
Tests of dehydration are imprecise, and, generally, there is only fair-to-moderate agreement with the examiner’s estimate. |
low |
Conditional |
|
|
|
ESPGHAN/ESPID 2014 |
The only laboratory measurement that appears to be useful in decreasing the likelihood of >5% dehydration is serum bicarbonate (normal serum bicarbonate). |
low |
Conditional |
|
|
|
ESPGHAN/ESPID 2014 |
Electrolytes should be measured in hospital settings: · In moderately dehydrated children whose history and physical examination findings are inconsistent with a severe diarrheal disease, and in all severely dehydrated children. In all children starting IV therapy, and during therapy, because hyper- or hyponatremia will alter the rate at which IV rehydration fluids will be given. |
Very low |
Conditional |
|
|
|
ESPGHAN/ESPID 2014 |
There is no indication for endoscopy except in selected circumstances or cases such as differential diagnosis with IBD at its onset. |
Very low |
conditional |
|
|
|
|
|
|
|
|
Table 8:Home Management |
|
|
|||
|
A- ORS |
|
|
|||
|
N |
Health questions |
Source Guideline |
Recommendations |
Quality of evidence |
Strength of Recommendation |
|
Home management ORS |
ESPGHAN/ESPID 2014 |
Reduced osmolarity ORS (50/60 mmol/L Na+) should be used as first-line therapy for the management of children with AGE. |
High |
Strong |
|
|
|
|
ESPGHAN/ESPID 2014 |
Reduced osmolarity ORS is more effective than full strength ORS as measured by such important clinical outcomes as reduced stool output, reduced vomiting, and reduced need for supplemental IV therapy. |
High |
Strong |
|
|
|
WHO 2005 |
If ORS therapy fails, such children should be given ORS solution by nasogastric (NG) tube or Ringer's Lactate Solution intravenously (IV) (75 ml/kg in four hours), usually in hospital. After confirming that the signs of dehydration have improved, it is usually possible to resume ORS successfully. |
Good Practice Statement |
|
|
|
|
WHO 2005 |
ORS therapy should not be given in the following conditions: · Abdominal distension with paralytic ileus, which may be caused by opiate drugs (e.g. codeine, loperamide) and hypokalaemia. Glucose malabsorption, indicated by a marked increase in stool output. |
Good Practice Statement |
|
|
|
|
||||
|
A. Nutrition |
|
|
|||
|
N |
Health questions |
Source Guideline |
Recommendations |
Quality of evidence |
Strength of Recommendation |
|
ESPGHAN/ESPID 2014 |
Early resumption of feeding after rehydration therapy is recommended. Further studies are, however, needed to determine whether the timing of refeeding affects the duration of diarrhea, total stool output, or weight gain in childhood acute diarrhea. |
High |
Strong |
||
|
|
|
ESPGHAN/ESPID 2014 |
The routine use of lactose-free feeds is presently not recommended in outpatient setting. |
High |
Strong |
|
|
|
ESPGHAN/ESPID 2014 |
There is insufficient evidence to recommend in favor or against the use of diluted lactose-containing milk. |
High |
Strong |
|
|
|
ESPGHAN/ESPID 2014 |
The bread, rice, apple, toast (BRAT) diet has not been studied and is not recommended. |
Very low |
conditional |
|
|
|
ESPGHAN/ESPID 2014 |
Beverages with a high sugar content should not be used. |
low |
conditional |
|
Pharmacology Therapy: |
|
|
|||
|
N |
Health questions |
Source Guideline |
Recommendations |
Quality of evidence |
Strength of Recommendation |
|
A1 |
ESPGHAN/ESPID 2014 |
Children age> 6 months in developing countries may benefit from the use of zinc in the treatment of AGE; however, in regions where zinc deficiency is rare, no benefit from the use of zinc is expected. |
High |
Strong |
|
|
|
|
ESPGHAN/ESPID 2014 |
Folic acid is not recommended for the management of children with AGE. |
Intermediate |
Strong |
|
|
|
ESPGHAN/ESPID 2014 |
Active treatment with probiotics, in adjunct to ORS, is effective in reducing the duration and intensity of symptoms of gastroenteritis. Selected probiotics can be used in children with AGE. |
High |
Strong |
|
|
|
ESPGHAN/ESPID 2014 |
The use of the following probiotics should be considered in the management of children with AGE as an adjunct to rehydration therapy: L rhamnosus GG and S boulardii. |
High |
Strong |
|
|
|
ESPGHAN/ESPID 2014 |
Ondansetron, at the dosages used in the available studies and administered orally or intravenously, may be effective in young children with vomiting related to AGE. Before a final recommendation is made, a clearance on safety in children is, however, needed. |
Intermediate |
Strong |
|
|
|
ESPGHAN/ESPID 2014 |
There is no evidence to support the use of other antiemetics. |
Intermediate |
Strong |
|
|
|
ESPGHAN/ESPID 2014 |
Loperamide is not recommended in the management of AGE in children. |
Intermediate |
Strong |
|
|
|
ESPGHAN/ESPID 2014 |
Smectite can be considered in the management of AGE. |
Intermediate |
Strong |
|
|
|
ESPGHAN/ESPID 2014 |
Smectite plus LGG and LGG alone are equally effective in the treatment of young children with AGE. Combined use of the 2 interventions is not justified. |
Intermediate |
Strong |
|
|
|
ESPGHAN/ESPID 2014 |
Other absorbents (namely, kaolin–pectin and attapulgite-activated charcoal) are not recommended. |
Low |
Conditional |
|
|
|
ESPGHAN/ESPID 2014 |
Racecadotril can be considered in the management of AGE. |
Intermediate |
Strong |
|
|
|
ESPGHAN/ESPID 2014 |
Bismuth subsalicylate is not recommended in the management of children with AGE. |
Low |
Conditional |
|
|
|
ESPGHAN/ESPID 2014 |
New evidence has confirmed that probiotics are effective in reducing the duration of symptoms in children with AGE. |
High |
Strong |
|
|
|
ESPGHAN/ESPID 2014 |
The use of prebiotics in the management of children with AGE is not recommended. |
Intermediate |
Strong |
|
Home management |
|
|
||||
|
Anti- Infective Therapy |
|
|
||||
|
N |
Health questions |
Source Guideline |
Recommendations |
Quality of evidence |
Strength of Recommendation |
|
|
ESPGHAN/ESPID 2014 |
Anti-infective therapy should not be given to the vast majority of otherwise healthy children with acute gastroenteritis. |
Very Low |
Conditional |
|||
|
|
|
ESPGHAN/ESPID 2014 |
Antibiotic therapy for acute bacterial gastroenteritis is not needed routinely but only for specific pathogens or in defined clinical settings. |
Very Low |
Conditional |
|
|
|
|
ESPGHAN/ESPID 2014 |
The choice of the antimicrobial agent depends on the local prevalence of the 3 pathogens (Shigella spp, Campylobacter spp, and Salmonella enterica) and the resistance patterns. |
Very Low |
Conditional |
|
|
|
|
ESPGHAN/ESPID 2014 |
In children with watery diarrhea, antibiotic therapy is not recommended unless the patient has recently traveled or may have been exposed to cholera. |
Very Low |
Conditional |
|
|
|
|
ESPGHAN/ESPID 2014 |
Bloody diarrhea with low or no fever is typical of STEC (enterohemorrhagic E coli), but can be mild shigellosis or salmonellosis. Antibiotics are not recommended unless epidemiology suggests shigellosis. |
Very Low |
Conditional |
|
|
|
|
ESPGHAN/ESPID 2014 |
Parenteral rather than oral antibiotic therapy is recommended for: · Patients unable to take oral medications (vomiting, stupor, etc) · Patients with underlying immune deficiency who have AGE with fever · Severe toxemia, suspected or confirmed bacteremia Neonates and young infants (< 3 months) with fever. Sepsis workup and antibiotics should be considered according to local protocols. |
Very Low |
Conditional |
|
|
|
|
ESPGHAN/ESPID 2014 |
Antiparasitic treatment is generally not needed in otherwise healthy children; however, it may be considered if symptoms are severe. |
Low |
conditional |
|
|
|
|
ESPGHAN/ESPID 2014 |
Severe cases of giardiasis can be treated with metronidazole, nitazoxanide, albendazole, or tinidazole. |
Low |
conditional |
|
|
|
|
ESPGHAN/ESPID 2014 |
Cryptosporidiasis should be treated mainly in immunocompromised children with nitazoxanide. |
Low |
conditional |
|
|
|
|
ESPGHAN/ESPID 2014 |
Amebic colitis should be treated with metronidazole. |
Low |
conditional |
|
|
|
|
ESPGHAN/ESPID 2014 |
Specific antiviral treatment is usually not indicated in AGE. |
Very Low |
Conditional |
|
|
|
|
ESPGHAN/ESPID 2014 |
Severe cytomegalovirus colitis, especially in an immunocompromised child, should be treated with ganciclovir. |
Low |
conditional |
|
|
Hospital Management |
|
|
||||
|
Hospitalization |
|
|
||||
|
N |
Health questions |
Source Guideline |
Recommendations |
Quality of evidence |
Strength of Recommendation |
|
|
ESPGHAN/ESPID 2014 |
The recommendations for hospital admission are based on consensus and include any of the following conditions: · Shock · Severe dehydration (>9% of body weight) · Neurological abnormalities (lethargy, seizures, etc) · Intractable or bilious vomiting · Failure of oral rehydration · Suspected surgical condition Conditions for a safe follow-up and home management are not met. |
Very low |
Conditional |
|||
|
|
|
ESPGHAN/ESPID 2014 |
Contact precautions are advised in addition to standard precautions (hand hygiene, personal protective equipment, soiled patient-care equipment, environmental control including textiles, laundry and adequate patient placement). |
Very low |
Conditional |
|
|
|
|
ESPGHAN/ESPID 2014 |
Prompt discharge from hospital should be considered in children admitted for AGE when the following conditions are fulfilled: · Sufficient rehydration is achieved as indicated by weight gain and/or clinical status · IV fluids are no longer required · Oral intake equals or exceeds losses Medical follow-up is available via telephone or office visit. |
Very low |
Conditional |
|
|
2- Rehydration therapy (enteral and parenteral): |
||||||
|
|
|
ESPGHAN/ESPID 2014 |
When oral rehydration is not feasible, enteral rehydration by the nasogastric (NG) route is the preferred method of rehydration, and should be proposed before IV rehydration. |
High |
Strong |
|
|
|
|
ESPGHAN/ESPID 2014 |
Enteral rehydration is associated with significantly fewer major adverse events and a shorter hospital stay than IV rehydration and is successful in most children. |
High |
Strong |
|
|
|
|
ESPGHAN/ESPID 2014 |
The rapid (40–50 mL/kg within 3–6 hours) and standard (24 hours) NG rehydration regimens are equally effective and may be recommended. |
Intermediate |
Strong |
|
|
|
|
ESPGHAN/ESPID 2014 |
IV fluids are required in the following cases: · Shock · Dehydration with altered level of consciousness or severe acidosis · Worsening of dehydration or lack of improvement despite oral or enteral rehydration therapy · Persistent vomiting despite appropriate fluid administration orally or via an NG tube Severe abdominal distension and ileus. |
Very low |
Conditional |
|
|
|
|
ESPGHAN/ESPID 2014 |
Children presenting with shock secondary to AGE should receive rapid IV infusion of isotonic crystalloid solution (0.9% saline or lactated Ringer’s solution) with a 20-mL/kg bolus. |
Very Low |
Conditional |
|
|
|
|
ESPGHAN/ESPID 2014 |
If the blood pressure has not improved after the first bolus, a second (or even a third) bolus of 20 mL/kg should be administered >10 to 15 minutes and other possible causes of shock should be considered. |
Very Low |
Conditional |
|
|
|
|
ESPGHAN/ESPID 2014 |
Children with severe dehydration requiring IV fluids may receive rapid rehydration with 20mL/kg/h of 0.9% saline solution for 2 to 4 hours. |
Intermediate |
Strong |
|
|
|
|
ESPGHAN/ESPID 2014 |
In IV-rehydrated children, a dextrose-containing solution may be used for maintenance. |
Low |
Conditional |
|
|
|
|
ESPGHAN/ESPID 2014 |
A solution containing not <0.45% saline (at least 77 mmol/L [Na+]) is recommended during the first 24 hours of IV rehydration therapy to prevent hyponatremia. |
Low |
Conditional |
|
|
|
|
ESPGHAN/ESPID 2014 |
After the child starts to urinate and if serum electrolyte values are known, add 20 mmol/L of K+ chloride. |
Very Low |
Conditional |
|
|
|
|
ESPGHAN/ESPID 2014 |
Rapid rehydration with 20mL/kg/h for 2 to 4 hours followed by oral rehydration or continuous infusion of dextrose solution is adequate for initial rehydration of most patients requiring hospital assistance. |
Intermediate |
Strong |
|
|
|
|
ESPGHAN/ESPID 2014 |
More rapid IV rehydration may be associated with electrolyte abnormalities and is associated with long time to hospital discharge, and therefore is not recommended. |
Intermediate |
Strong |
|
|
|
|
ESPGHAN/ESPID 2014 |
Isotonic (0.9%) saline solution effectively reduces the risk of hyponatremia and is recommended for initial rehydration in most cases. In the rare but extremely severe cases of shock, Ringer’s lactate solution is recommended. |
Low |
Conditional |
|
|
|
|
ESPGHAN/ESPID 2014 |
Glucose may be added to saline solution once fluid volume has been restored in the subsequent phase of IV rehydration (‘‘maintenance’’). |
Low |
Conditional |
|
|
Management of electrolyte imbalance: |
||||||
|
|
Management Of Hypernatremia: |
ESPGHAN/ESPID 2014 |
Oral or NG rehydration with hypo osmolar ORS is an effective and safe treatment and has fewer adverse effects than IV rehydration. |
Low |
Conditional |
|
|
|
|
ESPGHAN/ESPID 2014 |
If the child is hypernatremia and needs IV rehydration: · Use an isotonic solution (0.9% saline) for fluid deficit replacement and maintenance. · Replace the fluid deficit slowly, typically for 48 hours, with the aim of reducing it to <0.5mmol/L/h. Monitor plasma sodium frequently. |
Low |
Conditional |
|
|
|
Management of Hyponatremia |
WHO 2005 |
ORS solution is safe and effective therapy for nearly all children with hyponatremia. An exception is children with oedema, for whom ORS solution provides too much sodium. |
Good Practice Statement |
|
|
|
|
Management of Hypokalemia |
WHO 2005 |
Hypokalemia is worsened when base (bicarbonate or lactate) is given to treat acidosis without simultaneously providing potassium. |
Good Practice Statement |
|
|
|
|
|
WHO 2005 |
Hypokalaemia can be prevented, and the potassium deficit corrected, by using ORS solution for rehydration therapy and by giving foods rich in potassium during diarrhea and after it has stopped. |
|
|
|
|
Prevention: |
||||||
|
1- Strategies: |
||||||
|
|
|
IDSA 2017 |
Hand hygiene should be performed after using the toilet, changing diapers, before and after preparing food, before eating, after handling garbage or soiled laundry items, and after touching animals or their feces or environments, especially in public settings such as petting zoos. |
Intermediate (moderate) |
Strong |
|
|
|
|
IDSA 2017 |
Infection control measures including use of gloves and gowns, hand hygiene with soap and water, or alcohol-based sanitizers should be followed in the care of people with diarrhea. |
High |
Strong |
|
|
|
|
IDSA 2017 |
The selection of a hand hygiene product should be based upon a known or suspected pathogen and the environment in which the organism may be transmitted. |
low |
Strong |
|
|
|
|
IDSA 2017 |
Appropriate food safety practices are recommended to avoid cross-contamination of other foods or cooking surfaces and utensils during grocery shopping, food preparation, and storage; ensure that foods containing meats and eggs are cooked and maintained at proper temperatures. |
moderate |
Strong |
|
|
|
|
IDSA 2017 |
Healthcare providers should direct educational efforts toward all people with diarrhea, but particularly to people with primary and secondary immune deficiencies, pregnant women, parents of young children, and the elderly as they have increased risk of complications from diarrheal disease. |
low |
Strong |
|
|
|
|
IDSA 2017 |
Ill people with diarrhea should avoid swimming, water-related activities, and sexual contact with other people when symptomatic while adhering to meticulous hand hygiene. |
low |
Strong |
|
|
2- Vaccination |
||||||
|
|
|
IDSA 2017 |
Rotavirus vaccine should be administered to all infants without a known contraindication. |
high |
Strong |
|
|
|
|
IDSA 2017 |
Two typhoid vaccines (oral and injectable) are licensed in the United States but are not recommended routinely. Typhoid vaccination is recommended as an adjunct to hand hygiene and the avoidance of high-risk foods and beverages, for travelers to areas where there is moderate to high risk for exposure to Salmonella enterica subspecies enterica serovar Typhi, people with intimate exposure (eg, household contact) to a documented Salmonella enterica subspecies enterica serovar Typhi chronic carrier, and microbiologists and other laboratory personnel routinely exposed to cultures of Salmonella enterica subspecies enterica serovar Typhi. Booster doses are recommended for people who remain at rik. |
high |
Strong |
|